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Abstract
Organophosphate poisoning can present as acute cholinergic syndrome, Intermediate syndrome and delayed
neuropathy. Intermediate syndrome secondary to organophosphate poisoning is a serious health problem leading
to increased morbidity and mortality. The incidence of problem varies and range from 8%-84% of organophosphate
poisoning cases. The factors account for this difference is nature of organophosphate compound, severity of
poisoning and inadequate Oxime therapy. The recognition of this syndrome is important as organophosphate
poisoning is common in our country. We presented this case of organophosphate poisoning leading to prolonged
intermediate syndrome. The muscle weakness associated with this syndrome generally resolves in 5-18 days but in
our case this lasted for 23 days. After a prolonged Intensive Care Unit (ICU) stay patient was discharged home with
no residual symptoms. The case highlights anticipation and recognition of this problem after cholinergic crisis is over.
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features. Nasogastric lavage was performed. She was also atropinized
and started on pralidoxime. She was admitted to special care unit.

Introduction

Her symptoms improved within 48 hours of treatment as she was
planned to be shifted to general ward prior to discharge when she
developed respiratory distress with peripheral cyanosis. Her pulse
oximetry revealed hypoxia and she was started on high flow oxygen via
facemask. She then developed an episode of Generalized Tonic Clonic
seizures during which she was intubated and was shifted to ICU.

Organophosphate (OP) pesticide contributes significantly to
morbidity and mortality related to poisoning in the developing world
[1-3]. It generally present initially as acute cholinergic crisis which
manifest as excessive salivation, lacrimation, sweating, vomiting,
diarrhea, urination, pinpoint pupil, mental status changes and seizures.
In some patient after acute cholinergic crisis is over an Intermediate
syndrome of muscle weakness develops leading to respiratory failure
[1-3]. Some cases have delayed complications like organophosphate
induced delayed polyneuropathy and chronic organophosphate
induced neuropsychiatric disorder. Most of the deaths occur during
acute cholinergic crisis or during Intermediate syndrome of muscle
weakness [3-5].
The incidence of Intermediate syndrome reported in literature
varies and range from 8% - 84% of cases of organophosphate poisoning
[3]. Various factor accounts for this difference, including the nature of
OP compound, severity of poisoning and inadequate Oxime therapy
etc. [3]. The syndrome occurs after the acute cholinergic crisis is over
and patient is clinically improved. It manifests as acute muscle paralysis
especially involving neck flexors, proximal muscles, cranial nerve palsy
and respiratory muscles and therefore requires ventilator support [6].
Certain OP like parathion, methylparathion, malathion, and fenthion
are commonly associated with this condition [6]. The recognition of
this syndrome and its anticipation is important as apparently well
patient suddenly develop respiratory failure leading to high morbidity
and mortality.
We report a case of a 23 year old female with Organophosphate
poisoning who was successfully treated with pralidoxime and atropine,
in the acute phase of poisoning but suddenly developed respiratory
failure that lasted for twenty three ICU days.

Case Report

On improvement of her GCS in ICU it was noted that she had
decreased power in her limbs. On examination she had objective
weakness of all limbs (lower limbs greater than upper limbs) and deep
tendon reflexes were depressed in upper and lower limbs. Cranial
nerves and sensory examination were normal. Toxicology faculty at
our institute diagnosed her as a case of Intermediate Syndrome (IMS).
Multiple attempts to extubate the patient failed due to persistent
respiratory muscle weakness. She was also having excessive secretions
requiring continuous infusion of atropine and pralidoxime. Her
Electromyography (EMG) revealed significant decrement on fast
frequency Repetitive Nerve Stimulation (RNS) consistent with
neuromuscular junction disorder secondary to organophosphate
poisoning. MRI brain with contrast and Lumbar puncture were normal.
Her seizures were attributed to a recurrence of her childhood epilepsy
by the neurologist and it was precipitated by hypoxia due to respiratory
failure.
She stayed in ICU for 23 days and required a tracheostomy for
successful weaning from ventilator and discharge from hospital.
At follow up 6 weeks after discharge, she did not show any residual/
recurrence of her symptoms and her tracheostomy was removed.
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A 23 year old young lady brought to the Emergency Department
(ED) by family one hour after ingesting a bottle of an unknown
insecticide. On arrival, she was having excessive secretion and multiple
episodes of vomiting. She had 2 episodes of vomiting while in ED.
On examination she was tachycardic and had pinpoint pupils. Patient
was suspected to have organophosphate poisoning based on clinical
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Discussion
Our case highlighted a prolonged duration of an intermediate
syndrome requiring ICU and ventilator support for about 23 days.
According to Gold frank’s toxicological emergencies [6], the muscle
weakness, in general, resolves in 5 to 18 days, whereas this lasted
longer in our case report. The maximum reported time of resolution
in the literature is 30 days [3]. This is a huge burden on already scarce
medical resources in the developing country. OP poisoning is common
in developing world and regulation of pesticide control is not adequate
in our country [2].
We also highlight through this case report that although
organophosphate poisoning is common and published literature [2,7-9]
is available from our country but we could not find a single case report or
case series on this important entity from our country. Studies published
on organophosphate poisoning from our country [2,7-9] has described
clinical presentation of cholinergic excess, investigation, management
and outcome of patient but no description of intermediate syndrome.
Although hazardous pesticide is easily available in the market, the entity
might be going unrecognized or unpublished. Therefore the risk as well
as incidence in our setting is unknown. Recognition of the Intermediate
syndrome will help us identify the risk existing in our community and
thus will help plan intervention accordingly.
Recognition of signs of muscle weakness before full blown
respiratory failure happens is also important. This patient developed
shortness of breath initially then cyanosis and then followed by Tonic
Clonic seizure. An assessment of muscle weakness at the time of
complain of difficulty breathing would help avoid precipitating seizure
episode. Another problem is inadequate labeling of pesticide product.
The product ingested by patient was sold as pesticide but we could not
identify the exact ingredient of the product as there was no labeling.
We generally treat these patients based on clinical finding of
cholinergic excess in our setting. Labeling of product will help

anticipating this important cause of morbidity and mortality. Banning
of product associated with intermediate syndrome would be another
desirable intervention.

Conclusion
Intermediate syndrome contributes to morbidity and mortality.
Early recognition will help in prompt ventilator support. We
recommend that patient with acute organophosphate poisoning should
be assessed for muscle weakness after cholinergic crisis is over to
anticipate impending respiratory arrest due to intermediate syndrome.
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